Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma

NAActive, not recruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Brain Cancer
Interventions
DEVICE

Optune (NovoTTF-100A)

Trial Locations (9)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering West Harrison, Harrison

11725

Memorial Sloan Kettering Cancer Center at Commack, Commack

Unknown

Cedars-Sinai Medical Center, Los Angeles

University of Colorado, Denver

University of Miami, Miami

Memorial Sloan Kettering Cancer Center, Basking Ridge

Columbia University, New York

University of Cincinnati, Cincinnati

All Listed Sponsors
collaborator

NovoCure Ltd.

INDUSTRY

collaborator

Columbia University

OTHER

collaborator

University of Cincinnati

OTHER

collaborator

University of Colorado, Denver

OTHER

collaborator

University of Miami

OTHER

collaborator

Cedars-Sinai Medical Center

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER